We now show that a selective and potent allosteric inhibitor of Akt1 and Akt2 effectively inhibits Akt signaling in tumor bearing mice without gross toxicity or weight loss even when administered chronically (Figures 4 and 5 and S2). The gene discussed is AKT2; the disease is neoplasm.